We are committed to advancing clinical solutions in women's health, maternal-fetal health, and preterm birth. By focusing on the complex microenvironment—including both adaptive and innate immune responses—we develop cutting-edge computational and microfluidic tissue models of the female reproductive tract, placenta, lung, and lymph node to uncover the mechanisms driving disease progression and drug transport.

Our transdisciplinary approach integrates experimental biology, computational modeling, and machine learning to design targeted drug delivery strategies with therapeutic impact. With a strong emphasis on translational science, we aim to move discoveries efficiently from the bench to the bedside—and ultimately, to the market. We are driven by a passion for solving real-world health challenges.